ALNY

Q: What is the price of Alnylam Pharmaceuticals (ALNY) today?

The current price of Alnylam Pharmaceuticals (ALNY) is $ 339.41. The stock began the year trading around $ 397.65 and is currently priced at $ 339.41. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Alnylam Pharmaceuticals (ALNY) pay dividends?

Alnylam Pharmaceuticals (ALNY) did not pay dividends over the past year.

Alnylam Pharmaceuticals Inc.

Price

$ 339.41

return (12m)

p/e

68.23

p/bv

36.62

DIVIDEND YIELD

0.00%

ALNY price

Alnylam Pharmaceuticals

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ALNY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ALNY

review the fundamentals of Alnylam Pharmaceuticals shares

P/E

68.23

Sector: -4.09 Industry: -4.09

P/Receita (PSR)

9.19

Sector: -3.87 Industry: -3.87

P/BV

36.62

Sector: 1.89 Industry: 1.89

Dividend Yield (DY)

0.00%

Sector: - Industry: -

Payout

0.00%

Sector: - Industry: -

Net Profit Margins

13.46%

Sector: -39.07% Industry: -39.07%

Gross Margin

80.83%

Sector: 37.83% Industry: 37.83%

Margem Operacional

17.54%

Sector: -39.17% Industry: -39.17%

Margem EBIT

24.93%

Sector: - Industry: -

Margem EBITDA

26.09%

Sector: - Industry: -

EV/EBITDA

122.77

Sector: - Industry: -

EV/EBIT

128.49

Sector: - Industry: -

EV/EBITDA

42.60

Sector: -3.91 Industry: -3.91

EV/EBIT

45.28

Sector: -4.18 Industry: -4.18

P/Ativo

7.68

Sector: 1.39 Industry: 1.39

P/Cap Giro

13.72

Sector: - Industry: -

P/Ativo Circ Líq

238.48

Sector: - Industry: -

BVPS

8.09

Sector: 1.88 Industry: 1.88

EPS

4.34

Sector: -2.04 Industry: -2.04

Giro de Ativos

0.23

Sector: - Industry: -

ROE

53.67%

Sector: -61.00% Industry: -61.00%

ROIC

75.94%

Sector: -2,142.55% Industry: -2,142.55%

ROA

11.25%

Sector: -61.28% Industry: -61.28%

Dívida Líquida / Patrimônio

-1.86

Sector: - Industry: -

Dívida Líquida / EBITDA

-6.57

Sector: - Industry: -

Dívida Líquida / EBIT

-6.87

Sector: - Industry: -

Dívida Bruta / Patrimônio

0.94

Sector: - Industry: -

Patrimônio / Ativos

0.21

Sector: 0.42 Industry: 0.42

Passivos / Ativos

0.79

Sector: 0.38 Industry: 0.38

Liquidez Corrente

3.13

Sector: - Industry: -

CAGR Receitas 5 Anos

38.40%

Sector: - Industry: -

CAGR Lucros 5 Anos

0.00%

Sector: - Industry: -

FAIR VALUE OF Alnylam Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$339.41

Fair Value

$28.11

Upside/Downside Return potential.

-91.72%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ALNY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
AZN	27.54	6.04	21.93%	1.73%	$286.16 B	17.19%
JNJ	26.01	6.74	25.92%	2.29%	$547.30 B	21.83%
NBIX	27.51	4.05	14.71%	0.00%	$13.17 B	16.73%
ABEO	4.20	1.88	44.71%	0.00%	$298.65 M	100.00%
PFE	19.27	1.61	8.35%	6.53%	$149.71 B	12.42%
ABBV	100.54	0.00	0.00%	3.22%	$365.48 B	5.79%
ACAD	9.54	3.04	31.86%	0.00%	$3.73 B	36.49%
ADMA	17.04	5.25	30.78%	0.00%	$2.50 B	28.80%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ALNY Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

23 years

Founded: 2003

2004

Time since IPO - 22 years

1.453

Employees

Alnylam Pharmaceuticals Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $39.38 billion, with shareholders equity totaling $1.08 billion.

The company employs approximately 1.453 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, Alnylam Pharmaceuticals Inc. reported $4.29 billion in revenue, generating net income of $577.21 million.

Key financial metrics include a P/E ratio of 68.23, a price-to-book (P/B) ratio of 36.62, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ALNY.

Market cap

$39.38 billion

Net worth

$1.08 billion

$ 1,075,380,000.00

Assets

$5.13 billion

$ 5,129,550,000.00

Total Shares Outstanding

133.00 million

133,000,000

Average Daily Trading Volume

$1.13 million

$ 1,129,915.22

Sector

Healthcare

Industry

Biotecnologia

ALNY

revenue by Business Segment Alnylam Pharmaceuticals

ALNY revenue and profits

Financial Results ALNY

DRAG THE FRAME TO SEE MORE DATA

ALNY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 21,75% (12M)

P/E

23.07

0.39%

ROE

-4,383.84%

P/BV

-1,011.36

CAH - Cardinal Health

$214.95 41,04% (12M)

P/E

29.51

1.05%

ROE

-58.20%

P/BV

-17.17

JNJ - Johnson & Johnson

$240.16 60,65% (12M)

P/E

26.01

2.29%

ROE

25.92%

P/BV

6.74

PFE - Pfizer

$27.11 25,77% (12M)

P/E

19.27

6.53%

ROE

8.35%

P/BV

1.61

MRK - Merck & Co.

$119.96 60,16% (12M)

P/E

31.01

2.96%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$204.64 42,91% (12M)

P/E

27.54

1.73%

ROE

21.93%

P/BV

6.04

ABBV - AbbVie

$210.26 15,72% (12M)

P/E

100.54

3.22%

ROE

0.00%

P/BV

0.00

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$862.96 21,75% (12 M)

P/L

23.07

0.39%

ROE

-4,383.84%

P/VP

-1,011.36

CAH - Cardinal Health

$214.95 41,04% (12 M)

P/L

29.51

1.05%

ROE

-58.20%

P/VP

-17.17

JNJ - Johnson & Johnson

$240.16 60,65% (12 M)

P/L

26.01

2.29%

ROE

25.92%

P/VP

6.74

PFE - Pfizer

$27.11 25,77% (12 M)

P/L

19.27

6.53%

ROE

8.35%

P/VP

1.61

MRK - Merck & Co.

$119.96 60,16% (12 M)

P/L

31.01

2.96%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$204.64 42,91% (12 M)

P/L

27.54

1.73%

ROE

21.93%

P/VP

6.04

ABBV - AbbVie

$210.26 15,72% (12 M)

P/L

100.54

3.22%

ROE

0.00%

P/VP

0.00

Frequently Asked Questions

What is the price of Alnylam Pharmaceuticals (ALNY) today?

The current price of Alnylam Pharmaceuticals (ALNY) is $ 339.41. The stock began the year trading around $ 397.65 and is currently priced at $ 339.41. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Alnylam Pharmaceuticals (ALNY) pay dividends?

Alnylam Pharmaceuticals (ALNY) did not pay dividends over the past year.

Is Alnylam Pharmaceuticals (ALNY) a good investment?

Alnylam Pharmaceuticals (ALNY) is currently trading at $ 339.41 with a P/E ratio of 68.23. This represents a 912% premium compared to its historical average P/E. Over the past year, the stock paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Alnylam Pharmaceuticals (ALNY) stock?

You can buy Alnylam Pharmaceuticals (ALNY) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ALNY and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Alnylam Pharmaceuticals (ALNY) yield today?

Over the past month, Alnylam Pharmaceuticals (ALNY) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Alnylam Pharmaceuticals (ALNY) today at the current price of $ 339.41 your total investment would be $ 33,941.00.

Based on historical performance, the investment would have grown to approximately:

$ 33,941.00 after 1 year
$ 33,941.00 after 5 years
$ 33,941.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ALNY

Alnylam Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ALNY

review the fundamentals of Alnylam Pharmaceuticals shares

P/E

P/Receita (PSR)

P/BV

Dividend Yield (DY)

Payout

Net Profit Margins

Gross Margin

Margem Operacional

Margem EBIT

Margem EBITDA

EV/EBITDA

EV/EBIT

EV/EBITDA

EV/EBIT

P/Ativo

P/Cap Giro

P/Ativo Circ Líq

BVPS

EPS

Giro de Ativos

ROE

ROIC

ROA

Dívida Líquida / Patrimônio

Dívida Líquida / EBITDA

Dívida Líquida / EBIT

Dívida Bruta / Patrimônio

Patrimônio / Ativos

Passivos / Ativos

Liquidez Corrente

CAGR Receitas 5 Anos

CAGR Lucros 5 Anos

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

Alnylam Pharmaceuticals Inc.

States of America

23 years

2004

1.453

PROFIT X PRICE ALNY

Financial Results ALNY

ALNY cash flow

Asset, Revenue and Profit Growth - ALNY

ALNY balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

Frequently Asked Questions